{
    "Trade/Device Name(s)": [
        "Elecsys FT4 III"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K181233",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131244"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEC"
    ],
    "Summary Letter Date": "August 2, 2018",
    "Summary Letter Received Date": "August 3, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1695"
    ],
    "Regulation Name(s)": [
        "Free thyroxine test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Free thyroxine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Li-Heparin tube",
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas e 411 immunoassay analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Diagnostics Elecsys FT4 III assay for quantitative determination of free thyroxine using ECLIA on cobas e 411 analyzer",
    "Indications for Use Summary": "Assay for in vitro quantitative determination of free thyroxine in human serum and plasma to aid in diagnosis and treatment of thyroid disease using ECLIA on the cobas e 411 immunoassay analyzer.",
    "fda_folder": "Clinical Chemistry"
}